Zymeworks Inc. - ZYME
About Gravity Analytica
Recent News
- 06.11.2025 - Goldman Sachs Global Healthcare Conference
- 06.11.2025 - Goldman Sachs Global Healthcare Conference
- 06.04.2025 - Jefferies Global Healthcare Conference
- 06.04.2025 - Jefferies Global Healthcare Conference
- 05.30.2025 - Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
- 05.30.2025 - Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
- 05.30.2025 - Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
- 05.29.2025 - Yaron Werber
- 05.29.2025 - Yaron Werber
- 05.22.2025 - Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences